** Shares in Eurofins Scientific EUFI.PA fall 9% after the French testing and laboratory services provider posted a quarterly update below expectations
** The company's Q1 revenue came in at 1.79 billion euros ($2.10 billion), missing consensus by around 2%, driven by weak +2.6% organic growth, also "well below" +4.8% consensus, says Jefferies
** The broker notes weakness in North America, BioPharma, Life divisions, while Food/Feed activities were impacted by severe weather
** ICAP Midcap deems the publication "disappointing" organically
** Shares are on track for their worst day since October 2024, if losses hold
($1 = 0.8511 euros)
(Reporting by Olivier Cherfan)
((olivier.cherfan@thomsonreuters.com))